PharmaCorp Rx closes Western Canada pharmacy acquisition for $2.47 million
Reuters2026/08/18 12:04- PharmaCorp Rx closed its purchase of a PharmaChoice Canada pharmacy in Western Canada for about $2.47 million.
- The deal lifts its operating network to 16 pharmacies; the purchase was funded with existing cash resources.
- A separate agreement targets another PharmaChoice Canada pharmacy for about $1.3 million, with closing expected around Sept. 30, 2026.
- That transaction would raise the network to 17 pharmacies; the pharmacy is set to keep its current managing pharmacist during transition.
- Another deal values I.D.A. pharmacy prescription files at about $475,000, with closing expected around Sept. 7, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AutoCanada Profitability Seen Normalizing by 4Q -- Market Talk
Strategists warn: Gamma is extremely unstable! U.S. stocks with "ultra-low correlation" are facing the risk of violent shocks
This year, the low correlation in the U.S. stock market has been mainly driven by leading AI companies, but capital is shifting from semiconductor sectors towards lagging areas such as SaaS, narrowing the dispersion and weakening the foundation for low correlation. Bloomberg strategists warn that under abnormal Gamma volatility, a turn to negative could cause options dealers to reverse their hedging direction, amplifying market fluctuations. While the current index is less than 1% below its high, a 3% to 4% pullback could trigger a sharp Gamma reversal, putting the seemingly calm market at risk of dramatic volatility.
Web3: Bitcoin under pressure as miners, ETF, and strategy buying slow down
Bluesky Digital calls shareholder meeting on ChessGold acquisition
